Animal experiments using a DSS-induced colitis-mouse model revealed that oral administration of Trp, abundantly contained in ED, attenuated inflammation, and its effective mechanism may involve a decrease in TNF-α and an increase in IL-10. This evidence concerns the gene TNF and colitis.